摘要
目的为恶性肿瘤合并静脉血栓栓塞使用利伐沙班进行抗凝治疗提供参考。方法回顾性分析1例外院使用那曲肝素钙治肺癌合并静脉血栓栓塞患者的临床资料,包括血小板减少情况、诊疗过程、抗凝治疗方案和治疗结果。结果采用利伐沙班抗凝及升血小板药物治疗后,血小板恢复正常,静脉栓塞症状好转。结论利伐沙班可作为肿瘤合并静脉血栓栓塞的抗凝治疗。
Objective To provide reference for the use of rivaroxaban in anticoagulant therapy for patients with malignant tumor complicated with venous thromboembolism. Methods The clinical data including thrombocytopenia,diagnosis and treatment process,anticoagulant therapy plan and treatment result of a patient with lung cancer complicated with venous thromboembolism treated with nadroparin calcium in an another hospital were analyzed retrospectively. Results After the patient received rivaroxaban anticoagulation and platelet elevation therapy,the platelets returned to normal and the symptoms of venous thromboembolism improved. Conclusion Rivaroxaban can be used as an anticoagulant therapy for patients with tumors complicated with venous thromboembolism.
作者
鲍蕾蕾
曹爱霖
李莹
王占坤
钱皎
BAO Leilei;CAO Ailin;LI Ying;WANG Zhankun;QIAN Jiao(Department of Medicinal Materials,Changhai Hospital of the Second Military Medical University,Shanghai,China 200433)
出处
《中国药业》
CAS
2019年第21期77-79,共3页
China Pharmaceuticals
关键词
血小板减少
那曲肝素钙
利伐沙班
抗凝
静脉血栓栓塞
合理用药
thrombocytopenia
nadroparin calcium
rivaroxaban
anticoagulation
venous thromboembolism
rational drug use